NEUROCRINE BIOSCIENCES INC ($NBIX)
Filing Information
| Accession Number | 0001567160-26-000007 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 17, 2026 |
| Document Date | Feb 12, 2026 |
| Document | View SEC Filing |
Transactions
13
Total Shares
174,989
Total Value
$1,315,577.56
P&L
+inf% (+$18,945,107.40)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Feb 12, 2026 | Exercise/Conversion | 4,907 | $0.00 | $0.00 | 146,661 | Direct | โ | View Details | |
Director | Common Stock | โ | Feb 12, 2026 | Tax Withholding | 2,648 | $123.10 | $325,968.80 | 144,013 | Direct | โ | View Details | |
Director | Common Stock | โ | Feb 13, 2026 | Exercise/Conversion | 2,241 | $0.00 | $0.00 | 146,254 | Direct | โ | View Details | |
Director | Common Stock | โ | Feb 13, 2026 | Tax Withholding | 1,210 | $124.12 | $150,185.20 | 145,044 | Direct | โ | View Details | |
Director | Common Stock | โ | Feb 13, 2026 | Exercise/Conversion | 2,566 | $0.00 | $0.00 | 147,610 | Direct | โ | View Details | |
Director | Common Stock | โ | Feb 13, 2026 | Tax Withholding | 1,385 | $124.12 | $171,906.20 | 146,225 | Direct | โ | View Details | |
Director | Common Stock | โ | Feb 13, 2026 | Grant/Award | 9,968 | $0.00 | $0.00 | 156,193 | Direct | โ | View Details | |
Director | Common Stock | โ | Feb 13, 2026 | Tax Withholding | 5,378 | $124.12 | $667,517.36 | 150,815 | Direct | โ | View Details | |
Director | Restricted Stock Unit | Derivative | Feb 12, 2026 | Exercise/Conversion | 4,907 | $0.00 | $0.00 | 14,721 | Direct | โ | View Details | |
Director | Restricted Stock Unit | Derivative | Feb 13, 2026 | Exercise/Conversion | 2,241 | $0.00 | $0.00 | 4,484 | Direct | โ | View Details | |
Director | Restricted Stock Unit | Derivative | Feb 13, 2026 | Exercise/Conversion | 2,566 | $0.00 | $0.00 | 2,566 | Direct | โ | View Details | |
Director | Stock Option | Derivative | Feb 13, 2026 | Grant/Award | 114,830 | $0.00 | $0.00 | 114,830 | Direct | โ | View Details | |
Director | Restricted Stock Unit | Derivative | Feb 13, 2026 | Grant/Award | 20,142 | $0.00 | $0.00 | 20,142 | Direct | โ | View Details |